Disordered breathing in a Pitt-Hopkins syndrome model involves Phox2b-expressing parafacial neurons and aberrant Nav1.8 expression.
Colin M ClearyS JamesB J MaherDaniel K MulkeyPublished in: Nature communications (2021)
Pitt-Hopkins syndrome (PTHS) is a rare autism spectrum-like disorder characterized by intellectual disability, developmental delays, and breathing problems involving episodes of hyperventilation followed by apnea. PTHS is caused by functional haploinsufficiency of the gene encoding transcription factor 4 (Tcf4). Despite the severity of this disease, mechanisms contributing to PTHS behavioral abnormalities are not well understood. Here, we show that a Tcf4 truncation (Tcf4tr/+) mouse model of PTHS exhibits breathing problems similar to PTHS patients. This behavioral deficit is associated with selective loss of putative expiratory parafacial neurons and compromised function of neurons in the retrotrapezoid nucleus that regulate breathing in response to tissue CO2/H+. We also show that central Nav1.8 channels can be targeted pharmacologically to improve respiratory function at the cellular and behavioral levels in Tcf4tr/+ mice, thus establishing Nav1.8 as a high priority target with therapeutic potential in PTHS.
Keyphrases
- intellectual disability
- autism spectrum disorder
- spinal cord
- transcription factor
- mental health
- mouse model
- end stage renal disease
- poor prognosis
- ejection fraction
- chronic kidney disease
- obstructive sleep apnea
- prognostic factors
- gene expression
- cancer therapy
- genome wide
- peritoneal dialysis
- metabolic syndrome
- copy number
- genome wide identification
- dna binding
- insulin resistance
- drug delivery
- long non coding rna
- mechanical ventilation
- intensive care unit